Cephalon, Inc. v. Slayback Pharma Limited
| SLAYBACK PHARMA LIMITED LIABILITY COMPANY, APOTEX CORP., APOTEX INC. and MYLAN LABORATORIES LIMITED |
| FRESENIUS KABI USA, LLC |
| TEVA PHARMACEUTICALS INTERNATIONAL GMBH, EAGLE PHARMACEUTICALS, INC. and CEPHALON, INC. |
| 20-2136 |
| August 6, 2020 |
| U.S. Court of Appeals, Federal Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 24, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 12 Note to File: The following cases are consolidated: 20-2134 Lead with 20-2136 and 20-2137 Consolidated Member Cases. The parties must file all documents in the lead appeal only. [716966] [20-2134, 20-2136, 20-2137] [KMH] [Entered: 08/24/2020 01:37 PM] |
Filing 11
ORDER consolidating appeals 20-2134, 20-2136, and 20-2137. Appellants' opening briefs are due no later than October 5, 2020. Service as of this date by the Clerk of Court. [716929] [20-2134, 20-2136, 20-2137] [KMH] [Entered: 08/24/2020 12:44 PM]
|
| Filing 10 Docketing Statement for the Appellant Fresenius Kabi USA, LLC. Service: 08/20/2020 by email. [716312] [20-2136] [Imron Aly] [Entered: 08/20/2020 04:20 PM] |
| Filing 9 Certificate of Interest for Appellant Fresenius Kabi USA, LLC. Service: 08/20/2020 by email. [716310] [20-2136] [Imron Aly] [Entered: 08/20/2020 04:18 PM] |
| Filing 8 Entry of appearance for Imron T. Aly; Kevin M. Nelson as counsel for Appellant Fresenius Kabi USA, LLC. Service: 08/20/2020 by email. [716307] [20-2136] [Imron Aly] [Entered: 08/20/2020 04:14 PM] |
| Filing 7 Docketing Statement for the Appellee Eagle Pharmaceuticals, Inc.. Service: 08/20/2020 by email. [716239] [20-2136] [Daniel Brown] [Entered: 08/20/2020 03:04 PM] |
| Filing 6 Certificate of Interest for Appellee Eagle Pharmaceuticals, Inc.. Service: 08/20/2020 by email. [716238] [20-2136] [Daniel Brown] [Entered: 08/20/2020 03:02 PM] |
| Filing 5 Entry of appearance for Daniel G. Brown; Marc N. Zubick; Kenneth G. Schuler; Gabriel K. Bell as counsel for Appellee Eagle Pharmaceuticals, Inc.. Service: 08/20/2020 by email. [716235] [20-2136] [Daniel Brown] [Entered: 08/20/2020 03:00 PM] |
| Filing 4 Docketing Statement for the Appellees Cephalon, Inc. and Teva Pharmaceuticals International GmbH. Service: 08/20/2020 by email. [716153] [20-2136] [Ben Picozzi] [Entered: 08/20/2020 12:49 PM] |
| Filing 3 Certificate of Interest for Appellees Cephalon, Inc. and Teva Pharmaceuticals International GmbH. Service: 08/20/2020 by email. [716152] [20-2136] [Ben Picozzi] [Entered: 08/20/2020 12:48 PM] |
| Filing 2 Entry of appearance for David I. Berl; Adam D. Harber; Shaun P. Mahaffy; Ben Picozzi; Matthew W. Lachman as counsel for Appellees Cephalon, Inc. and Teva Pharmaceuticals International GmbH. Service: 08/20/2020 by email. [716150] [20-2136] [Ben Picozzi] [Entered: 08/20/2020 12:47 PM] |
| Filing 1 Appeal docketed. Received: 08/05/2020. [713034] Entry of Appearance is due on 08/20/2020. Certificate of Interest is due on 08/20/2020. Docketing Statement is due on 08/20/2020. Appellant's brief is due on 10/05/2020. [KMH] [Entered: 08/06/2020 01:06 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
